FDA withdraws Covid antibody treatment Evusheld because it's not effective against 93% of subvariants

Many take Evusheld as an additional layer of protection because the vaccines do not trigger a strong immune response for them.

from Health and Science https://ift.tt/XKIpFu2
https://ift.tt/Op0yeqC
https://ift.tt/cJjgwVR

No comments

Powered by Blogger.